A phase 1 enzyme replacement study offers promise for severe hypophospahatasia

Clin Genet. 2012 Sep;82(3):220-1. doi: 10.1111/j.1399-0004.2012.01912.x. Epub 2012 Jul 12.

Author

Affiliation

¹ Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, 950 West 28th Avenue, Vancouver, BC V5Z4H4, Canada. alicehaw@exchange.ubc.ca

PMID: 22697134
DOI: 10.1111/j.1399-0004.2012.01912.x

No abstract available

Publication types

Comment